 Severity of Illness Index
"Severity of Illness Index" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
| Descriptor ID |
D012720
|
| MeSH Number(s) |
E05.318.308.980.438.475.456.500 N05.715.360.300.800.438.375.364.500 N06.850.520.308.980.438.475.364.500
|
| Concept/Terms |
Severity of Illness Index- Severity of Illness Index
- Illness Index Severities
- Illness Index Severity
- Index Severities, Illness
- Index Severity, Illness
|
Below are MeSH descriptors whose meaning is more general than "Severity of Illness Index".
Below are MeSH descriptors whose meaning is more specific than "Severity of Illness Index".
This graph shows the total number of publications written about "Severity of Illness Index" by people in this website by year, and whether "Severity of Illness Index" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 | | 1996 | 0 | 1 | 1 | | 1997 | 1 | 10 | 11 | | 1998 | 0 | 6 | 6 | | 1999 | 1 | 17 | 18 | | 2000 | 0 | 22 | 22 | | 2001 | 2 | 21 | 23 | | 2002 | 3 | 30 | 33 | | 2003 | 2 | 45 | 47 | | 2004 | 1 | 51 | 52 | | 2005 | 3 | 72 | 75 | | 2006 | 4 | 59 | 63 | | 2007 | 8 | 76 | 84 | | 2008 | 3 | 91 | 94 | | 2009 | 11 | 63 | 74 | | 2010 | 8 | 89 | 97 | | 2011 | 11 | 97 | 108 | | 2012 | 11 | 85 | 96 | | 2013 | 16 | 92 | 108 | | 2014 | 11 | 111 | 122 | | 2015 | 5 | 113 | 118 | | 2016 | 16 | 97 | 113 | | 2017 | 17 | 95 | 112 | | 2018 | 10 | 126 | 136 | | 2019 | 17 | 123 | 140 | | 2020 | 11 | 93 | 104 | | 2021 | 15 | 89 | 104 | | 2022 | 1 | 33 | 34 | | 2023 | 1 | 22 | 23 | | 2024 | 18 | 65 | 83 | | 2025 | 3 | 35 | 38 |
To return to the timeline, click here.
Below are the most recent publications written about "Severity of Illness Index" by people in Profiles.
-
Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 Nov; 248:108340.
-
McMichael A, Shahriari M, Stein Gold L, Alkousakis T, Choi O, Bhutani T, Rodriguez AO, Tyring SK, Chan D, Rowland K, Albrecht L, Lynde C, Yadav G, Yeung J, Park-Wyllie L, Ma T, Jeyarajah J, Gao LL, Smith S, Moore AY, Vashi N, Kindred C, Grimes P, Desai SR, Taylor SC, Alexis A. Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial. JAMA Dermatol. 2025 Sep 01; 161(9):912-922.
-
Alexis A, McMichael A, Soung J, Choi O, Alkousakis T, Alonso-Llamazares J, Shahriari M, Rodriguez AO, Bhutani T, Chan D, Rowland K, Sauder M, Hong HC, Yadav G, Yeung J, Jeyarajah J, Ma T, Gao LL, Park-Wyllie L, Green L, Lee M, Vashi N, Kindred C, Grimes P, Taylor SC, Desai SR. Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial. JAMA Dermatol. 2025 Sep 01; 161(9):901-911.
-
Shimamura A, Maschan A, Bennett C, Samarasinghe S, Farrar JE, Li CK, Sirachainan N, Pongtanakul B, Komvilaisak P, Zubarovskaya L, Rothman JA, Walkovich K, Nakano TA, Bertuch AA, Ferrao A, Bhat R, Hanna R, Overholt K, Boklan J, Wong TF, Wang Q, Urban P, Strahm B, Wang W, Vlachos A, Williams DA. Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial. Blood Adv. 2025 Aug 12; 9(15):3728-3738.
-
Morani I, Shibli H, Karasik D, Edelstein M. Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated risk scoring. BMC Infect Dis. 2025 Aug 04; 25(1):977.
-
Swigris JJ, Pryor JB, Aronson KI, Guess TA, Solomon JJ. Using Bookmarking to Reveal Dyspnea Severity Categorizations According to Patients with Interstitial Lung Disease and the Physicians Who Treat Them. Ann Am Thorac Soc. 2025 Aug; 22(8):1147-1154.
-
Luo AJ, Arkin LM, Asch S, Benjamin L, Bruckner AL, Cossio ML, Diaz L, Lilly E, Mathes EF, Nelson CA, Pope E, Ramachandran S, Siegel DH, Teng JMC, Xu Y, Deng Y, Paller AS, Choate KA. Reliability of the Ichthyosis Scoring System in Individuals With Skin of Color. JAMA Dermatol. 2025 Aug 01; 161(8):849-854.
-
Hanson KA, Austin J, Clayton N, Anderson P, Vano-Galvan S, Marwaha S, Kurosky SK, Lejeune A, Piercy J, Law EH. Patient-Reported Psychosocial Burdens and Quality of Life and Work Productivity Impacts Among Patients with Clinically Distinct Alopecia Areata Severity Profiles. Adv Ther. 2025 Sep; 42(9):4556-4570.
-
Joshi VA, Bucholz EM, Roll M, Rahman N, Kolte D, Davila C, Yeh RW, Cohen DJ, Waldo SW, Butala NM. Sex Differences in Stroke Frequency and Severity Following Transcatheter Aortic Valve Replacement. J Am Heart Assoc. 2025 Aug 05; 14(15):e041943.
-
Wheeler AP, Cibelli E, Hanson G, Percier C, Porstmann T, Shridhar N, Shapiro A. Treatment and Disease Burden in a Cohort of People With Haemophilia Without Inhibitors in the United States. Haemophilia. 2025 Sep; 31(5):912-921.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|